Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
14.37
+0.04 (0.28%)
At close: Feb 27, 2026, 4:00 PM EST
14.35
-0.02 (-0.14%)
After-hours: Feb 27, 2026, 6:15 PM EST
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 247.03M | 206.15M | 146.94M | | | | | | | |
| 19.83% | 40.29% | 26.93% | | | | | | | |
| 351.67M | 322.15M | 252.42M | | | | | | | |
Outside of U.S. Revenue Growth | 9.16% | 27.63% | 18.24% | | | | | | | |
| 598.70M | 528.30M | 399.36M | | | | | | | |
| 13.33% | 32.29% | 21.30% | | | | | | | |
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 498.96M | 458.05M | 387.78M | | | | | | | |
| 8.93% | 18.12% | 17.85% | | | | | | | |
Pombiliti and Opfolda Revenue | 99.74M | 70.24M | 11.58M | | | | | | | |
Pombiliti and Opfolda Revenue Growth | 42.00% | 506.62% | 6091.98% | | | | | | | |
| 598.70M | 528.30M | 399.36M | | | | | | | |
| 13.33% | 32.29% | 21.30% | | | | | | | |
Updated Nov 4, 2025. Data Source:
Fiscal.ai.
